Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes [NA]

View source ↗

Summary

This clinical trial update compares the Omnipod SmartAdjust 2.0 insulin pump system with the Omnipod 5 system in individuals with Type 1 or Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omnipod 5 System
  • Omnipod SmartAdjust 2.0 System

Snippet

Sponsor: Insulet Corporation | Conditions: Diabetes Mellitus, Type 1, Type 2 | NA | Status: COMPLETED